Risultati per: Linee-guida GOLD 2023,cosa cambia?
Questo è quello che abbiamo trovato per te
Linee guida sulla diagnosi e il trattamento delle infezioni del piede diabetico
Linee guida sulla gestione farmacologica dell’emicrania
Case 16-2023: A 13-Year-Old Boy with Depression and Hypotension
New England Journal of Medicine, Volume 388, Issue 21, Page 1992-1999, May 2023.
Linea guida sulla gestione farmacologica della costipazione idiopatica cronica
Linee guida sulla gestione dell’Acne Vulgaris
Ritardo bando di concorso per la formazione specifica in medicina generale 2023
Schembri (FIMMG Formazione): “Siamo a quasi 80 giorni di ritardo dai termini previsti per legge. Conseguenze? Meno Medici di Medicina Generale sul territorio, più cittadini senza Medico di Famiglia. Chiediamo pubblicazione bandi entro l’estate e concorso a novembre, con inizio effettivo entro la fine del 2023”
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Stroke, Ahead of Print. AIM:The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with aneurysmal subarachnoid hemorrhage.METHODS:A comprehensive search for literature published since the 2012 guideline, derived from research principally involving human subjects, published in English, and indexed in MEDLINE, PubMed, Cochrane Library, and other selected databases relevant to this guideline, was conducted between March 2022 and June 2022. In addition, the guideline writing group reviewed documents on related subject matter previously published by the American Heart Association. Newer studies published between July 2022 and November 2022 that affected recommendation content, Class of Recommendation, or Level of Evidence were included if appropriate.STRUCTURE:Aneurysmal subarachnoid hemorrhage is a significant global public health threat and a severely morbid and often deadly condition. The 2023 aneurysmal subarachnoid hemorrhage guideline provides recommendations based on current evidence for the treatment of these patients. The recommendations present an evidence-based approach to preventing, diagnosing, and managing patients with aneurysmal subarachnoid hemorrhage, with the intent to improve quality of care and align with patients’ and their families’ and caregivers’ interests. Many recommendations from the previous aneurysmal subarachnoid hemorrhage guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.
Correction to: 2023 ISC Poster Abstract TP112
Stroke, Volume 54, Issue 6, Page e293-e293, June 1, 2023.
June 2023 Stroke Highlights
Stroke, Volume 54, Issue 6, Page 1463-1463, June 1, 2023.
Treatment of Brugada Syndrome in 2023: Know Where You Come From to Know Where You Are Going
Circulation, Volume 147, Issue 21, Page 1579-1581, May 23, 2023.
Case 15-2023: A 33-Year-Old Man with Paresthesia of the Arms and Legs
New England Journal of Medicine, Volume 388, Issue 20, Page 1893-1900, May 2023.
Boom di test per lo streptococco in farmacia, +2.000% nel 2023
Iqvia, di pari passo +28% vendite dell’antibiotico amoxicillina
Annals for Educators – May 2023
Annals of Internal Medicine, Volume 176, Issue 5, May 2023.
Annals for Hospitalists – May 2023
Annals of Internal Medicine, Volume 176, Issue 5, May 2023.
Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in 2022-2023
This study uses data from the US Department of Veterans Affairs to assess whether SARS-CoV-2 remains associated with higher risk of death compared with seasonal influenza in fall-winter 2022-2023.